Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.

Abstract:

OBJECTIVE:To understand better the true impact of widespread adoption of adjuvant aromatase inhibitor (AI) therapy on postmenopausal breast cancer patients' risk of bone fracture. METHODS:Data from three different studies were used to estimate the relative risk of bone fracture for each of the following groups of women (i.e., versus a control group of healthy postmenopausal women): (a) healthy postmenopausal women receiving tamoxifen; (b) postmenopausal women who had received treatment for early breast cancer; (c) postmenopausal breast cancer patients on adjuvant tamoxifen therapy; (d) postmenopausal breast cancer patients on adjuvant anastrozole therapy. The results of these analyses were then used to estimate the likely incidence of clinical fracture among such populations in 'real-life' clinical practice. RESULTS:Breast cancer survivors were calculated to be at increased risk of clinical bone fracture (i.e., RR 1.15 vs. control group over 5 years). Breast cancer patients initiated on adjuvant anastrozole were also calculated to be at increased risk of bone fracture (RR = 1.36 vs. control group over 5 years), while the calculated risk of fracture among tamoxifen-treated breast cancer patients was similar to that observed in the control population (RR = 0.91). CONCLUSION:Breast cancer patients are at increased risk of clinical bone fracture (compared with the general postmenopausal population) and adjuvant anastrozole therapy slightly adds to this risk. Importantly, however, the absolute risk of bone fracture appears to remain low in each of the evaluated patient populations, suggesting that fear of fracture should not prevent the initiation of adjuvant aromatase inhibitor therapy.

journal_name

Curr Med Res Opin

authors

Bell R,Lewis J

doi

10.1185/030079907x187919

subject

Has Abstract

pub_date

2007-05-01 00:00:00

pages

1045-51

issue

5

eissn

0300-7995

issn

1473-4877

journal_volume

23

pub_type

杂志文章
  • Survival analysis for all-cause revision following primary total hip arthroplasty with a medial collared, triple-tapered primary hip stem versus other implants in real-world settings.

    abstract:OBJECTIVE:Patients that undergo total hip replacement (THA) are at risk of revision surgery. This study evaluated the cumulative incidence of revision following a medial collared, triple tapered (MCTT) primary hip stem versus other implants in real-world settings using electronic medical records. METHODS:This was a re...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1822309

    authors: Chitnis AS,Mantel J,Ruppenkamp J,Bourcet A,Holy CE

    更新日期:2020-11-01 00:00:00

  • Neurogenic bladder and disc disease: a brief review.

    abstract:OBJECTIVE:Neurogenic bladder refers to morphofunctional alterations of the bladder-sphincter complex secondary to central or peripheral neurological lesions. Discal etiology can be suggested by clinical observation in patients complaining of classical lower back pain, but not excluded even without musculoskeletal pain....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2013.807788

    authors: Siracusa G,Sparacino A,Lentini VL

    更新日期:2013-08-01 00:00:00

  • Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.

    abstract:OBJECTIVE:Osteoarthritis is one of the most common forms of arthritis seen in primary care. Non-steroidal anti-inflammatory drugs (NSAIDs) play an important role in the management of osteoarthritis. However, gastrointestinal (GI) side effects limit their use. Cyclooxygenase-2 (COX-2) selective inhibitors exhibit better...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079906X104722

    authors: Pareek A,Chandanwale AS,Oak J,Jain UK,Kapoor S

    更新日期:2006-05-01 00:00:00

  • A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension.

    abstract::A large, open, multi-centre study was carried out in general practice to evaluate the effectiveness and tolerance of a combination of 10 mg pindolol plus 5 mg clopamide, in single tablet form, in the treatment of patients with essential hypertension. Computer analysis of the records of 8989 patients who completed the ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007997909109449

    authors: Crowder D,Cameron EG

    更新日期:1979-01-01 00:00:00

  • A comparative study of haloperidol and diazepam in the treatment of anxiety.

    abstract::In a single-blind study in general practice, 60 patients with anxiety neuroses were randomly allocated to receive either 0.5 mg haloperidol twice daily or 2 mg diazepam 3-times daily for 6 weeks. Eighteen patients (6 on haloperidol and 12 on diazepam) were excluded from the analysis of efficacy. On the Hamilton Rating...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997909109010

    authors: Budden MG

    更新日期:1979-01-01 00:00:00

  • Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey.

    abstract:OBJECTIVE:To determine the characteristics of asthma (A) and allergic rhinitis (AR) among asthma patients in primary care practice. RESEARCH DESIGN AND METHODS:Primary care physicians, pulmonologists, and allergologists were asked to recruit consecutive asthma patients with or without allergic rhinitis from their dail...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990902820733

    authors: Taegtmeyer AB,Steurer-Stey C,Spertini F,Bircher A,Helbling A,Miedinger D,Schafroth S,Scherer K,Leuppi JD

    更新日期:2009-05-01 00:00:00

  • Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.

    abstract:BACKGROUND:There is growing evidence describing DNA repair genes polymorphisms are related to increased cancer risk including colorectal cancer (CRC). The aim of this study was to investigate the associations between the APE1 Asp148Glu, hOGG1 Ser326Cys, XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln, XPG Asp1104His po...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2011.573544

    authors: Canbay E,Cakmakoglu B,Zeybek U,Sozen S,Cacina C,Gulluoglu M,Balik E,Bulut T,Yamaner S,Bugra D

    更新日期:2011-07-01 00:00:00

  • Xipamid, a potent new diuretic.

    abstract::The effects of xipamid and frusemide were comapred in 9 oedematous patients. Xipamid was found to be equipotent with frusemide in doses of 40 mg. and 80 mg., with respect to its effect on sodium and water excretion. The time course of action of xipamid was observed to be more prolonged than that of frusemide. It is co...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007997509113658

    authors: Piyasena KH,Havard CW,Weber JC

    更新日期:1975-01-01 00:00:00

  • Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study.

    abstract:OBJECTIVE:PREDICTIVE is a multi-national, prospective, observational study, assessing the safety and efficacy of insulin detemir in patients with diabetes. RESEARCH DESIGN AND METHODS:The European cohort includes 20,531 patients with diabetes (7420 type 1) from 11 countries. A subgroup of 4782 type 1 patients were tra...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/030079908x260835

    authors: Dornhorst A,Lüddeke HJ,Honka M,Ackermann RW,Meriläinen M,Gallwitz B,Sreenan S,PREDICTIVE Study Group.

    更新日期:2008-02-01 00:00:00

  • Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries.

    abstract:OBJECTIVE:To evaluate knowledge about risks, prevention and consequences of infection with hepatitis B virus (HBV) among travellers from four low HBV risk, European countries. METHODS:Individuals from an internet panel and based in the Czech Republic, the Netherlands, Spain and Sweden were invited to take part in an o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.546392

    authors: Herbinger KH,Nothdurft HD,Prymula R

    更新日期:2011-03-01 00:00:00

  • Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting.

    abstract:OBJECTIVE:To evaluate inpatient oral anticoagulant (OAC) treatment, discharge location, and post-discharge OAC treatment for patients hospitalized with non-valvular atrial fibrillation (NVAF). RESEARCH DESIGN AND METHODS:Retrospective study using claims data linked to hospital electronic health records (EHR). Patients...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1417029

    authors: Henk HJ,Cao F,Tuell K,Price K,Singh P,Mardekian J,Odell K,Patel C,Tan W,Sands GH,Singhal S,Trocio J,Vo L

    更新日期:2018-03-01 00:00:00

  • Abuse-deterrent opioids: an update on current approaches and considerations.

    abstract:OBJECTIVE:Abuse and misuse of prescription opioids is a significant public health concern. This review examines the strategies used to confer abuse-deterrent properties on opioid abuse-deterrent formulations (ADFs), the characteristics and supporting data for each of the available ADFs, and the role of opioid ADFs as p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2017.1419171

    authors: Pergolizzi JV Jr,Raffa RB,Taylor R Jr,Vacalis S

    更新日期:2018-04-01 00:00:00

  • Focus on quetiapine.

    abstract::Quetiapine fumarate is a novel dibenzothiazepine antipsychotic developed by Zeneca. It is marketed under the trade name 'Seroquel'. Quetiapine is well tolerated and clinically effective in the treatment of schizophrenia. The initial hope of investigators was that quetiapine would have antipsychotic potential and that ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007999909114085

    authors: Green B

    更新日期:1999-01-01 00:00:00

  • Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations.

    abstract::An investigator-blind, parallel-group, multicentre study was undertaken to compare the efficacy and tolerability of once-daily, sustained-release (s-r) ibuprofen and diclofenac sodium in patients (mean age 59.8 years) suffering from painful osteoarthritis affecting chiefly the knee and/or hip. Patients attending eight...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007999609115224

    authors: Baumgartner H,Schwarz HA,Blum W,Bruhin A,Gallachi G,Goldinger G,Saxer M,Trost H

    更新日期:1996-01-01 00:00:00

  • Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.

    abstract:OBJECTIVES:The objective of this project was to determine pharmacy cost savings and improvement in adherence based on a combinatorial pharmacogenomic test (CPGx ) in patients who had switched or added a new psychiatric medication after having failed monotherapy for their psychiatric disorder. RESEARCH DESIGN AND METHO...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1063483

    authors: Winner JG,Carhart JM,Altar CA,Goldfarb S,Allen JD,Lavezzari G,Parsons KK,Marshak AG,Garavaglia S,Dechairo BM

    更新日期:2015-01-01 00:00:00

  • Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss.

    abstract::A single-blind, open-label controlled study was carried out in 30 healthy male volunteers to compare gastro-intestinal blood loss before, during and after treatment with a new, sustained-release formulation of the non-steroidal anti-inflammatory agent etodolac (etodolac SR) or with naproxen. Subjects remained at the s...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007999209115217

    authors: Leese P

    更新日期:1992-01-01 00:00:00

  • Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study.

    abstract:OBJECTIVE:To assess the effect of an individualized genomic classifier (GC) test, for predicting metastasis following radical prostatectomy (RP), on urologists' adjuvant treatment decisions when caring for high-risk patients. PATIENTS AND METHODS:Data were submitted by US board-certified urologists in community practi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007995.2014.919908

    authors: Michalopoulos SN,Kella N,Payne R,Yohannes P,Singh A,Hettinger C,Yousefi K,Hornberger J,PRO-ACT Study Group.

    更新日期:2014-08-01 00:00:00

  • An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014.

    abstract:INTRODUCTION:GOLD guideline recommendations are currently the "gold standard" for the treatment of COPD patients. OBJECTIVES:The objective of this analysis was to evaluate compliance with GOLD guidelines in managing COPD patients' treatment by general practitioners (GPs) and pulmonologists. Since inhaled corticosteroi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1182900

    authors: Visentin E,Nieri D,Vagaggini B,Peruzzi E,Paggiaro P

    更新日期:2016-09-01 00:00:00

  • Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study.

    abstract:OBJECTIVE:Subcutaneous immunotherapy (SCIT) for allergic rhinitis (AR) has been shown to control symptoms for up to several years following treatment discontinuation, but the effect of SCIT on healthcare costs for commercially insured patients is unknown. The objective of this study was to compare healthcare costs and ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1359517

    authors: Allen-Ramey F,Mao J,Blauer-Peterson C,Rock M,Nathan R,Halpern R

    更新日期:2017-11-01 00:00:00

  • Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.

    abstract:OBJECTIVE:To perform an open, non-controlled, multiple-dose, international, multicentre, phase III study to evaluate epoetin zeta, a biosimilar epoetin referenced to epoetin alfa, for the treatment of chemotherapy-induced anaemia in patients with cancer. METHODS:Safety, tolerability and efficacy of subcutaneously admi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990903050876

    authors: Tzekova V,Mihaylov G,Elezovic I,Koytchev R,Epoetin Zeta Oncology Study Group.

    更新日期:2009-07-01 00:00:00

  • A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.

    abstract::In a double-blind trial in 26 patients with symptomatic gastro-oesophageal reflux, the alginate/effervescent/antacid compound 'Gaviscon' was compared with antacid containing placebo similarly formulated. Retrosternal pain after meals and at night was significantly reduced whilst patients were taking 'Gaviscon' and the...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997509114793

    authors: Barnardo DE,Lancaster-Smith M,Strickland ID,Wright JT

    更新日期:1975-01-01 00:00:00

  • Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?

    abstract:OBJECTIVE:To look into current evidence exploring the added value of rLH supplementation to rFSH in GnRH analogues cycles, to identify groups of women that still have no evidence for adjuvant rLH therapy and to discuss ways that may advance research on this topic. METHODS:Eight systematic reviews and meta-analyses exp...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1417827

    authors: Younis JS,Laufer N

    更新日期:2018-05-01 00:00:00

  • Management of emergent psychiatric symptoms during smoking cessation.

    abstract:BACKGROUND:Tobacco smoking is a major risk factor for cardiovascular disease, respiratory disease and cancer and, for current smokers, smoking cessation is one of the most effective therapeutic interventions for reducing the risk of all-cause morbidity and mortality. However, smoking cessation causes nicotine withdrawa...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802707600

    authors: Aubin HJ

    更新日期:2009-02-01 00:00:00

  • Patterns of pharmacologic treatment in US patients with acromegaly.

    abstract:OBJECTIVE:To establish a baseline pattern of care across academic and community settings, it is important to examine the contemporary treatment of acromegaly. We characterized medical treatment patterns for acromegaly in the US to develop a basis for tracking concordance with guidelines. RESEARCH DESIGN AND METHODS:Ac...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1125870

    authors: Broder MS,Chang E,Ludlam WH,Neary MP,Carmichael JD

    更新日期:2016-05-01 00:00:00

  • An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children.

    abstract::An open study was carried out in 41 children with mild to moderate psoriasis to assess the effectiveness and tolerance of treatment with a 0.1% dithranol plus 17% urea preparation applied twice daily. Thirty-four patients completed 6-weeks' treatment and 8 of them continued for a further 4 to 6 weeks. The results show...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007998309111752

    authors: Guerrier CJ,Porter DI

    更新日期:1983-01-01 00:00:00

  • Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction.

    abstract:OBJECTIVE:We evaluated the clinical efficacy of sacubitril/valsartan in a group of ambulatory patients with heart failure (HF) with reduced ejection fraction (HFrEF) referred to our HF clinic. METHODS:Patients (n = 29; 72% males; mean age 76 years) with HFrEF in New York Heart Association (NYHA) classes II-III were in...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2019.1576481

    authors: Cosentino ER,Degli Esposti D,Miceli R,Bentivenga C,Landolfo M,Fg Cicero A,Berardi E,Spinardi L,Magri G,Dugato V,Borghi C

    更新日期:2019-03-01 00:00:00

  • Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer.

    abstract:BACKGROUND:Eribulin mesylate (eribulin) is indicated for patients with metastatic breast cancer (MBC) who have previously received at least two chemotherapies in the US and for patients with locally advanced breast cancer (LABC) or MBC who have progressed after at least one chemotherapy in the European Union (EU). In b...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1835853

    authors: Chabot I,Zhao Q,Su Y

    更新日期:2020-12-01 00:00:00

  • Significance testing - are we ready yet to abandon its use?

    abstract::Understanding of the damaging effects of significance testing has steadily grown. Reporting p values without dichotomizing the result to be significant or not, is not the solution. Confidence intervals are better, but are troubled by a non-intuitive interpretation, and are often misused just to see whether the null va...

    journal_title:Current medical research and opinion

    pub_type: 信件

    doi:10.1185/03007995.2011.618493

    authors: The B

    更新日期:2011-11-01 00:00:00

  • A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement.

    abstract:OBJECTIVE:To evaluate the relative efficacy and safety of extended-release tramadol HCl 75 mg/acetaminophen 650 mg (TA-ER) and immediate-release tramadol HCl 37.5 mg/acetaminophen 325 mg (TA-IR) for the treatment of moderate to severe acute pain following total knee replacement. METHODS:This phase III, double-blind, p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007995.2014.975338

    authors: Park YB,Ha CW,Cho SD,Lee MC,Lee JH,Seo SS,Kang SB,Kyung HS,Choi CH,Chang N,Rhim HY,Bin SI

    更新日期:2015-01-01 00:00:00

  • Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis.

    abstract:OBJECTIVE:To compare the effectiveness of antiresorptive agents in reducing the risk of vertebral and non-vertebral fractures using data from published meta-analyses and the technique of adjusted indirect comparisons. RESEARCH DESIGN AND METHODS:Pairs of agents were compared by adjusted indirect comparison of 0.56 [0....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079904125003269

    authors: Wehren LE,Hosking D,Hochberg MC

    更新日期:2004-04-01 00:00:00